BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17763192)

  • 41. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation.
    Street ME; Seghini P; Ziveri MA; Fieni S; Volta C; Neri TM; Viani I; Bacchi-Modena A; Bernasconi S
    Growth Horm IGF Res; 2006; 16(5-6):365-72. PubMed ID: 17101288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
    Lee SD; Chen LM; Kuo WW; Shu WT; Kuo WH; Huang EJ; Tsai CC; Li PC; Liu JY; Chen TH; Huang CY
    Clin Chim Acta; 2006 May; 367(1-2):62-8. PubMed ID: 16406300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in the chicken following hatching.
    Radecki SV; Capdevielle MC; Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1997 Jul; 107(1):109-17. PubMed ID: 9208310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
    Ariza CR; Frati AC; Gómez G; Almazán A
    Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
    Ricart W; Fernández-Real JM
    Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
    Kawachi S; Takeda N; Sasaki A; Kokubo Y; Takami K; Sarui H; Hayashi M; Yamakita N; Yasuda K
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Mälarstig A; Brismar K; Hamsten A; Fisher RM; Hellénius ML
    Clin Sci (Lond); 2009 Mar; 116(6):507-12. PubMed ID: 18816247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
    Choi YS; Kim SH; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY
    Gynecol Obstet Invest; 2009; 67(2):73-80. PubMed ID: 18843190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary protein during gestation affects maternal insulin-like growth factor, insulin-like growth factor binding protein, leptin concentrations, and fetal growth in heifers.
    Sullivan TM; Micke GC; Perkins N; Martin GB; Wallace CR; Gatford KL; Owens JA; Perry VE
    J Anim Sci; 2009 Oct; 87(10):3304-16. PubMed ID: 19617516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication.
    Laurenzano E; Brevetti G; Lanero S; Brevetti L; Colao A; Chiariello M
    Int Angiol; 2009 Jun; 28(3):202-8. PubMed ID: 19506539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
    Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
    Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment.
    Zimmermann-Belsing T; Juul A; Juul Holst J; Feldt-Rasmussen U
    Growth Horm IGF Res; 2004 Jun; 14(3):235-44. PubMed ID: 15125885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating insulin-like growth factors in patients infected with Helicobacter pylori.
    Baricević I; Nedić O; Nikolić JA; Bojić B; Jojić N
    Clin Biochem; 2004 Nov; 37(11):997-1001. PubMed ID: 15498528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin resistance and body composition in preterm born children during prepubertal ages.
    Darendeliler F; Bas F; Bundak R; Coban A; Sancakli O; Eryilmaz SK; Kucukemre B; Disci R; Gokcay G; Aki S; Ince Z; Eskiyurt N
    Clin Endocrinol (Oxf); 2008 May; 68(5):773-9. PubMed ID: 17980003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
    Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
    Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.